title: AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
authors.affiliation: Gladstone Institute of Virology and Immunology, San Francisco, CA, USA. rgrant@itsa.ucsf.edu
authors.forename: Robert M
authors.initials: RM
authors.lastname: Grant
authors.forename: Susan
authors.initials: S
authors.lastname: Buchbinder
authors.forename: Willard
authors.initials: W
authors.lastname: Cates
authors.forename: Edith
authors.initials: E
authors.lastname: Clarke
authors.forename: Thomas
authors.initials: T
authors.lastname: Coates
authors.forename: Myron S
authors.initials: MS
authors.lastname: Cohen
authors.forename: Martin
authors.initials: M
authors.lastname: Delaney
authors.forename: Guiselly
authors.initials: G
authors.lastname: Flores
authors.forename: Pedro
authors.initials: P
authors.lastname: Goicochea
authors.forename: Gregg
authors.initials: G
authors.lastname: Gonsalves
authors.forename: Mark
authors.initials: M
authors.lastname: Harrington
authors.forename: Javier R
authors.initials: JR
authors.lastname: Lama
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: MacQueen
authors.forename: John P
authors.initials: JP
authors.lastname: Moore
authors.forename: Leigh
authors.initials: L
authors.lastname: Peterson
authors.forename: Jorge
authors.initials: J
authors.lastname: Sanchez
authors.forename: Melanie
authors.initials: M
authors.lastname: Thompson
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000349:Africa; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001208:Asia; D003256:Community Participation; D018849:Controlled Clinical Trials as Topic / Q000592:standards; D003376:Counseling; D003906:Developing Countries; D016527:Drug Costs; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D007843:Latin America; D008297:Male; D063065:Organophosphonates / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D018579:Patient Selection; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine